1
|
Halliday A, Long AE, Baum HE, Thomas AC, Shelley KL, Oliver E, Gupta K, Francis O, Williamson MK, Di Bartolo N, Randell MJ, Ben-Khoud Y, Kelland I, Mortimer G, Ball O, Plumptre C, Chandler K, Obst U, Secchi M, Piemonti L, Lampasona V, Smith J, Gregorova M, Knezevic L, Metz J, Barr R, Morales-Aza B, Oliver J, Collingwood L, Hitchings B, Ring S, Wooldridge L, Rivino L, Timpson N, McKernon J, Muir P, Hamilton F, Arnold D, Woolfson DN, Goenka A, Davidson AD, Toye AM, Berger I, Bailey M, Gillespie KM, Williams AJK, Finn A. Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2. Front Immunol 2022; 13:968317. [PMID: 36439154 PMCID: PMC9682908 DOI: 10.3389/fimmu.2022.968317] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Accepted: 08/30/2022] [Indexed: 11/11/2022] Open
Abstract
Low-volume antibody assays can be used to track SARS-CoV-2 infection rates in settings where active testing for virus is limited and remote sampling is optimal. We developed 12 ELISAs detecting total or antibody isotypes to SARS-CoV-2 nucleocapsid, spike protein or its receptor binding domain (RBD), 3 anti-RBD isotype specific luciferase immunoprecipitation system (LIPS) assays and a novel Spike-RBD bridging LIPS total-antibody assay. We utilized pre-pandemic (n=984) and confirmed/suspected recent COVID-19 sera taken pre-vaccination rollout in 2020 (n=269). Assays measuring total antibody discriminated best between pre-pandemic and COVID-19 sera and were selected for diagnostic evaluation. In the blind evaluation, two of these assays (Spike Pan ELISA and Spike-RBD Bridging LIPS assay) demonstrated >97% specificity and >92% sensitivity for samples from COVID-19 patients taken >21 days post symptom onset or PCR test. These assays offered better sensitivity for the detection of COVID-19 cases than a commercial assay which requires 100-fold larger serum volumes. This study demonstrates that low-volume in-house antibody assays can provide good diagnostic performance, and highlights the importance of using well-characterized samples and controls for all stages of assay development and evaluation. These cost-effective assays may be particularly useful for seroprevalence studies in low and middle-income countries.
Collapse
Affiliation(s)
- Alice Halliday
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Anna E. Long
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Holly E. Baum
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
- School of Chemistry, University of Bristol, Bristol, United Kingdom
| | - Amy C. Thomas
- Bristol Veterinary School, University of Bristol, Bristol, United Kingdom
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Kathryn L. Shelley
- School of Chemistry, University of Bristol, Bristol, United Kingdom
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
| | - Elizabeth Oliver
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Kapil Gupta
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
| | - Ore Francis
- Bristol Veterinary School, University of Bristol, Bristol, United Kingdom
| | | | - Natalie Di Bartolo
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
| | - Matthew J. Randell
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Yassin Ben-Khoud
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Ilana Kelland
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Georgina Mortimer
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Olivia Ball
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Charlie Plumptre
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Kyla Chandler
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Ulrike Obst
- School of Chemistry, University of Bristol, Bristol, United Kingdom
| | - Massimiliano Secchi
- Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Lorenzo Piemonti
- Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Vito Lampasona
- Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Joyce Smith
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Michaela Gregorova
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Lea Knezevic
- Bristol Veterinary School, University of Bristol, Bristol, United Kingdom
| | - Jane Metz
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
- Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, United Kingdom
| | - Rachael Barr
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
- Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, United Kingdom
| | - Begonia Morales-Aza
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Jennifer Oliver
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Lucy Collingwood
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Benjamin Hitchings
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Susan Ring
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
- MRC Integrative Epidemiology Unit at University of Bristol, Bristol, United Kingdom
| | - Linda Wooldridge
- Bristol Veterinary School, University of Bristol, Bristol, United Kingdom
| | - Laura Rivino
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Nicholas Timpson
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
- MRC Integrative Epidemiology Unit at University of Bristol, Bristol, United Kingdom
| | - Jorgen McKernon
- National Infection Service, UK Health Security Agency, Southmead Hospital, Bristol, United Kingdom
| | - Peter Muir
- National Infection Service, UK Health Security Agency, Southmead Hospital, Bristol, United Kingdom
| | - Fergus Hamilton
- MRC Integrative Epidemiology Unit at University of Bristol, Bristol, United Kingdom
- Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - David Arnold
- Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Derek N. Woolfson
- School of Chemistry, University of Bristol, Bristol, United Kingdom
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
- Bristol BioDesign Institute, University of Bristol, Bristol, United Kingdom
| | - Anu Goenka
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
- Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, United Kingdom
| | - Andrew D. Davidson
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Ashley M. Toye
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
- Bristol BioDesign Institute, University of Bristol, Bristol, United Kingdom
- Bristol Institute of Transfusion Sciences, NHS Blood and Transplant Filton, Bristol, United Kingdom
| | - Imre Berger
- School of Chemistry, University of Bristol, Bristol, United Kingdom
- School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, United Kingdom
- Bristol BioDesign Institute, University of Bristol, Bristol, United Kingdom
| | - Mick Bailey
- Bristol Veterinary School, University of Bristol, Bristol, United Kingdom
| | - Kathleen M. Gillespie
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Alistair J. K. Williams
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Adam Finn
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
- Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, United Kingdom
| |
Collapse
|
2
|
Williams GM, Leary S, Leadbetter S, Toms S, Mortimer G, Scorrer T, Gillespie K, Shield JPH. Establishing breast feeding in infants with Down syndrome: the FADES cohort experience. BMJ Paediatr Open 2022; 6:10.1136/bmjpo-2022-001547. [PMID: 36645743 PMCID: PMC9660693 DOI: 10.1136/bmjpo-2022-001547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Accepted: 10/10/2022] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVE To describe breastfeeding prevalence and maternal experience in infants with trisomy 21. DESIGN Longitudinal cohort study. SETTING Participants from UK recruited through websites, social media and local collaborators: neonatologists, community paediatricians and research nurses. SUBJECTS Infants under the age of 8 months with Down syndrome (DS) recruited to the Feeding and Autoimmunity in Down Syndrome Evaluation Study between 1 September 2014 and 31 August 2017. Seventy participants: median age 20 weeks (IQR 13-29 weeks) at initial questionnaire. MAIN OUTCOME MEASURE Breastfeeding prevalence at 6 weeks and 6 months among infants with DS. RESULTS The prevalence of exclusive breast feeding among study participants was similar to the general population (13/61, 21% vs 23% at 6 weeks, 2/54, 4% vs 1% at 6 months). However, the prevalence of breast feeding (exclusive or combination feeding) among the study participants was higher than the general population (39/61 64% vs 55% at 6 weeks, 32/59 54% vs 34% at 6 months). CONCLUSION Although there may be challenges in establishing breast feeding in infants with DS, our data suggest that exclusive breast feeding is possible for some, and the prevalence of breast feeding is comparable to the prevalence in the general population. TRIAL REGISTRATION NUMBER ISRCTN12415856.
Collapse
Affiliation(s)
- Georgina M Williams
- NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Bristol, UK .,Translational Health Sciences, University of Bristol, Bristol, UK.,Department of Paediatric Endocrinology, Noah's Ark Children's Hospital for Wales, Cardiff, UK
| | - Sam Leary
- NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Bristol, UK
| | - Sofia Leadbetter
- NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Bristol, UK
| | - Stu Toms
- NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Bristol, UK
| | | | - Tim Scorrer
- Neonatology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | | | - Julian P H Shield
- NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Bristol, UK
| |
Collapse
|
3
|
Tapia G, Mortimer G, Ye J, Gillard BT, Chipper-Keating S, Mårild K, Viken MK, Lie BA, Joner G, Skrivarhaug T, Njølstad PR, Størdal K, Gillespie KM, Stene LC. Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes. Pediatr Diabetes 2019; 20:728-735. [PMID: 31173445 DOI: 10.1111/pedi.12875] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 04/05/2019] [Accepted: 05/28/2019] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Maternal microchimerism (MMc), the transmission of small quantities of maternal cells to the fetus, is relatively common and persistent. MMc has been detected with increased frequency in the circulation and pancreas of type 1 diabetes (T1D) patients. We investigated for the first time whether MMc levels at birth predict future T1D risk. We also tested whether cord blood MMc predicted MMc in samples taken at T1D diagnosis. METHODS Participants in the Norwegian Mother and Child Cohort study were human leukocyte antigen (HLA) class II typed to determine non-inherited, non-shared maternal alleles (NIMA). Droplet digital (dd) polymerase chain reaction (PCR) assays specific for common HLA class II NIMA (HLADQB1*03:01, *04:02, and *06:02/03) were developed and validated. MMc was estimated as maternal DNA quantity in the fetal circulation, by NIMA specific ddPCR, measured in cord blood DNA from 71 children who later developed T1D and 126 controls within the cohort. RESULTS We found detectable quantities of MMc in 34/71 future T1D cases (48%) and 53/126 controls (42%) (adjusted odds ratio [aOR] 1.27, 95% confidence interval (CI) 0.68-2.36), and no significant difference in ranks of MMc quantities between cases and controls (Mann-Whitney P = .46). There was a possible association in the NIMA HLA-DQB1*03:01 subgroup with later T1D (aOR 3.89, 95%CI 1.05-14.4). MMc in cord blood was not significantly associated with MMc at T1D diagnosis. CONCLUSIONS Our findings did not support the hypothesis that the degree of MMc in cord blood predict T1D risk. The potential subgroup association with T1D risk should be replicated in a larger cohort.
Collapse
Affiliation(s)
- German Tapia
- Norwegian Institute of Public Health, Oslo, Norway
| | - Georgina Mortimer
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, UK
| | - Jody Ye
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, UK
| | - Benjamin T Gillard
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, UK
| | | | - Karl Mårild
- Norwegian Institute of Public Health, Oslo, Norway
| | - Marte K Viken
- Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway
| | - Benedicte A Lie
- Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.,Department of Medical Genetics, University of Oslo, Oslo, Norway
| | - Geir Joner
- Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Torild Skrivarhaug
- Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Pål R Njølstad
- Department of Pediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway.,KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway
| | - Ketil Størdal
- Norwegian Institute of Public Health, Oslo, Norway.,Pediatric Department, Østfold Hospital Trust, Grålum, Norway
| | - Kathleen M Gillespie
- Diabetes and Metabolism, Bristol Medical School, University of Bristol, Bristol, UK
| | - Lars C Stene
- Norwegian Institute of Public Health, Oslo, Norway
| |
Collapse
|
4
|
Mindos T, Dun XP, North K, Doddrell RDS, Schulz A, Edwards P, Russell J, Gray B, Roberts SL, Shivane A, Mortimer G, Pirie M, Zhang N, Pan D, Morrison H, Parkinson DB. Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. J Cell Biol 2017; 216:495-510. [PMID: 28137778 PMCID: PMC5294779 DOI: 10.1083/jcb.201606052] [Citation(s) in RCA: 72] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2016] [Revised: 10/23/2016] [Accepted: 12/27/2016] [Indexed: 02/06/2023] Open
Abstract
The regenerative capacity of Schwann cells in the PNS underlies functional repair after injury. In this study, Mindos et al. show a new function for the tumor suppressor Merlin and Hippo/YAP signaling in the generation of repair-competent Schwann cells after injury. Loss of the Merlin tumor suppressor and activation of the Hippo signaling pathway play major roles in the control of cell proliferation and tumorigenesis. We have identified completely novel roles for Merlin and the Hippo pathway effector Yes-associated protein (YAP) in the control of Schwann cell (SC) plasticity and peripheral nerve repair after injury. Injury to the peripheral nervous system (PNS) causes a dramatic shift in SC molecular phenotype and the generation of repair-competent SCs, which direct functional repair. We find that loss of Merlin in these cells causes a catastrophic failure of axonal regeneration and remyelination in the PNS. This effect is mediated by activation of YAP expression in Merlin-null SCs, and loss of YAP restores axonal regrowth and functional repair. This work identifies new mechanisms that control the regenerative potential of SCs and gives new insight into understanding the correct control of functional nerve repair in the PNS.
Collapse
Affiliation(s)
- Thomas Mindos
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Xin-Peng Dun
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Katherine North
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK.,University of Bath, Bath BA2 7AY, England, UK
| | - Robin D S Doddrell
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Alexander Schulz
- Leibniz Institute for Age Research - Fritz Lipmann Institute Jena, D-07745 Jena, Germany
| | - Philip Edwards
- Department of Cellular and Anatomical Pathology, Derriford Hospital, Plymouth PL6 8DH, England, UK
| | - James Russell
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Bethany Gray
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK.,University of Bath, Bath BA2 7AY, England, UK
| | - Sheridan L Roberts
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Aditya Shivane
- Department of Cellular and Anatomical Pathology, Derriford Hospital, Plymouth PL6 8DH, England, UK
| | - Georgina Mortimer
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Melissa Pirie
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| | - Nailing Zhang
- Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205
| | - Duojia Pan
- Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205
| | - Helen Morrison
- Leibniz Institute for Age Research - Fritz Lipmann Institute Jena, D-07745 Jena, Germany
| | - David B Parkinson
- Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth PL6 8BU, England, UK
| |
Collapse
|
5
|
Flaherty G, McCarthy P, Mortimer G. Pulmonary artery leiomyosarcoma: an unusual cause of shortness of breath. Ir J Med Sci 2009; 180:275-8. [PMID: 19921308 DOI: 10.1007/s11845-009-0451-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2008] [Accepted: 11/03/2009] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Primary leiomyosarcomas of the pulmonary artery are very rare tumours with 30 cases reported in the English literature. Herein, we report the first case with evidence of a renal metastasis. MATERIALS AND METHODS The tumour was discovered at autopsy in a 61-year-old woman who had presented with shortness of breath and chest pain. It was located in the pulmonary trunk with extension into the adjacent pericardial cavity. Separate nodules were found in the pulmonary valve, the left pulmonary artery and the left kidney. RESULTS On microscopic examination, the tumour was composed of spindle cells with cigar-shaped nuclei immunoreactive for vimentin, desmin, CD68 and α-smooth muscle actin. CONCLUSIONS Primary pulmonary artery leiomyosarcoma is easily confused clinically with pulmonary thromboembolism and most cases are diagnosed post mortem. Most tumours arise in the pulmonary trunk and metastases are only rarely described. The management of patients with this rare tumour depends on early surgical resection and the prognosis is unfavourable.
Collapse
Affiliation(s)
- G Flaherty
- Department of Medicine, University Hospital, Galway and National University of Ireland, Galway, Ireland.
| | | | | |
Collapse
|
6
|
Mortimer G, Long SV, Nibhrolcain C, Connolly CE. Histopathology of spontaneous abortion material: A comparative study of 403 cases. J OBSTET GYNAECOL 2009. [DOI: 10.3109/01443618909151123] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
7
|
Bolaji II, Mortimer G, Grimes H, O'dwyer EM. Endometrial response in oestrogenised postmenopausal women after treatment with oral progesterone: results of a prospective analysis. J OBSTET GYNAECOL 2009. [DOI: 10.3109/01443619209025947] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
8
|
von Conrady D, Smith MJ, Khan MF, Tan S, Mortimer G, McAnena OJ. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery. Endoscopy 2008; 40 Suppl 2:E68-9. [PMID: 18633915 DOI: 10.1055/s-2007-995507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Affiliation(s)
- D von Conrady
- Department of Surgery, University College Hospital Galway, Galway, Ireland.
| | | | | | | | | | | |
Collapse
|
9
|
Sedano S, Gaffney G, Mortimer G, Lyons M, Cleary B, Murray M, Maher M. Activated Protein C Resistance (APCR) and Placental Fibrin Deposition. Placenta 2008; 29:833-7. [DOI: 10.1016/j.placenta.2008.06.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/27/2007] [Revised: 05/30/2008] [Accepted: 06/25/2008] [Indexed: 11/28/2022]
|
10
|
Abstract
Small cell neuroendocrine carcinoma of the breast is a rare tumour with less than 30 cases reported in the literature. The clinicopathological findings of three cases of primary neuroendocrine carcinoma of the breast and a review of the pertinent literature are presented. The morphological and immunohistochemical patterns of this tumour are similar to its pulmonary counterpart. Expression of neuroendocrine markers is inconsistent, so morphology is the mainstay of diagnosis. Size is a very important prognostic factor in this tumour, as in breast carcinomas of the usual type.
Collapse
Affiliation(s)
- T Adegbola
- Department of Histopathology, University College Hospital, Galway, Republic of Ireland.
| | | | | |
Collapse
|
11
|
Sproule JA, Salmo E, Mortimer G, O'Sullivan M. Aneursymal bone cyst of the proximal phalanx of the thumb in a child. Hand Surg 2002; 7:147-50. [PMID: 12365056 DOI: 10.1142/s0218810402000959] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2001] [Accepted: 06/26/2001] [Indexed: 11/18/2022]
Abstract
Aneursymal Bone Cysts (ABCs) involving the hand are a rare occurrence. We report a case of an ABC of the proximal phalanx of the thumb in a boy which was treated successfully with curettage and autologous bone grafting. When the diagnosis of ABC of the small bones of the hand is entertained, prompt therapeutic intervention is indicated because of the potential for aggressive local behaviour. In the paediatric patient, simple surgery to preserve the growth plate is recommended.
Collapse
Affiliation(s)
- J A Sproule
- Departments of Orthopaedics, University College Hospital, Galway, Ireland.
| | | | | | | |
Collapse
|
12
|
Abstract
The internal displacement of populations in Burma is not a new phenomenon. Displacement is caused by numerous factors. Not all of it is due to outright violence, but much is a consequence of misguided social and economic development initiatives. Efforts to consolidate the state by assimilating populations in government-controlled areas by military authorities on the one hand, while brokering cease-fires with non-state actors on the other, has uprooted civilian populations throughout the country. Very few areas in which internally displaced persons (IDPs) are found are not facing social turmoil within a climate of impunity. Humanitarian access to IDP populations remains extremely problematic. While relatively little information has been collected, assistance has been focused on targeting accessible groups. International concern within Burma has couched the problems of displacement within general development modalities, while international attention along its borders has sought to contain displacement. With the exception of several recent initiatives, few approaches have gone beyond assistance and engaged in the prevention or protection of the displaced.
Collapse
Affiliation(s)
- S Lanjouw
- Chiang Mai University Post Office, Thailand.
| | | | | |
Collapse
|
13
|
GrüN R, Spooner NA, Thorne A, Mortimer G, Simpson JJ, Mcculloch MT, Taylor L, Curnoe D. Age of the Lake Mungo 3 skeleton, reply to Bowler & Magee and to Gillespie & Roberts. J Hum Evol 2000; 38:733-41. [PMID: 10799263 DOI: 10.1006/jhev.2000.0399] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- R GrüN
- Research School of Earth Sciences, The Australian National University, Canberra, ACT, 0200, Australia
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Mofidi A, Joyce M, Tansey D, Laing A, Mortimer G, Gilmore MX. Unusual case of pilomatricoma. Ir J Med Sci 2000; 169:149. [PMID: 11006677 DOI: 10.1007/bf03166924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Thorne A, Grün R, Mortimer G, Spooner NA, Simpson JJ, McCulloch M, Taylor L, Curnoe D. Australia's oldest human remains: age of the Lake Mungo 3 skeleton. J Hum Evol 1999; 36:591-612. [PMID: 10330330 DOI: 10.1006/jhev.1999.0305] [Citation(s) in RCA: 245] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We have carried out a comprehensive ESR and U-series dating study on the Lake Mungo 3 (LM3) human skeleton. The isotopic Th/U and Pa/U ratios indicate that some minor uranium mobilization may have occurred in the past. Taking such effects into account, the best age estimate for the human skeleton is obtained through the combination of U-series and ESR analyses yielding 62,000+/-6000 years. This age is in close agreement with OSL age estimates on the sediment into which the skeleton was buried of 61,000+/-2000 years. Furthermore, we obtained a U-series age of 81,000+/-21,000 years for the calcitic matrix that was precipitated on the bones after burial. All age results are considerably older than the previously assumed age of LM3 and demonstrate the necessity for directly dating hominid remains. We conclude that the Lake Mungo 3 burial documents the earliest known human presence on the Australian continent. The age implies that people who were skeletally within the range of the present Australian indigenous population colonized the continent during or before oxygen isotope stage 4 (57,000-71,000 years).
Collapse
Affiliation(s)
- A Thorne
- Research School of Pacific and Asian Studies, Australian National University, Canberra, ACT 0200, Australia
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Mulhall KJ, O'Hanlon DM, Mortimer G, Quill DS. Papillary carcinoma in a thyroglossal duct remnant--a review of thyroglossal surgery in a regional centre in the west of Ireland. Ir J Med Sci 1998; 167:212-5. [PMID: 9868856 DOI: 10.1007/bf02937414] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
A review of thyroglossal duct remnants presenting to a regional centre in the West of Ireland was undertaken. Over a 15 yr period, 25 patients were operated on for duct remnants. The mean age was 19.6 yr and ranged from 3 to 68 yr. There were 16 (64 per cent) males and 9 (36 per cent) females. Seventeen (68 per cent) patients were less than 20 years at the time of surgery. Four patients presented with a sinus and the remainder with a cystic lesion. Two patients experienced recurrent disease. One patient, a 41 yr old female, had a papillary carcinoma of a thyroglossal cyst. There were no clinical features distinguishing this patient from those with benign cystic remnants of the thyroglossal duct. The possibility of carcinoma in older patients, in particular females, presenting with thyroglossal cysts emphasises the importance of performing a formal Sistrunk's operation. It reduces the risk of recurrence of the cyst and may reduce the risk of recurrence of the tumour as the duct may provide a route for the spread of tumour.
Collapse
Affiliation(s)
- K J Mulhall
- Department of Surgery, University College Hospital, Galway, Ireland
| | | | | | | |
Collapse
|
17
|
Mortimer G. Post acute community care. Western Sydney Area Health Service (WSAHS). Lamp 1997; 54:13. [PMID: 9335752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
18
|
Abstract
The authors describe a case of early neonatal death of a full-term infant who had respiratory distress and anemia after fetal distress during labor. Postmortem examination disclosed mediastinal compression by a large fresh hemorrhage into the left lobe of the thymus. Massive thymic hemorrhage is an extremely rare but sometimes lethal occurrence; it may represent a manifestation of early-onset hemorrhagic disease of the newborn.
Collapse
Affiliation(s)
- S V Walsh
- Department of Histopathology, University College Hospital, Galway, Ireland
| | | | | | | |
Collapse
|
19
|
Bolaji II, Mortimer G, Grimes H, Tallon DF, O'Dwyer E, Fottrell PF. Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women. Gynecol Endocrinol 1996; 10:41-7. [PMID: 8737191 DOI: 10.3109/09513599609041269] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
In an open non-comparative prospective trial of 12 months' duration, we investigated the role of a novel hormone replacement therapy regimen in 40 post-menopausal women who sought hormone replacement therapy. The regimen consisted of continuous administration of 0.625 mg of conjugated equine estrogen coupled with a fixed low-dose of micronized oral progesterone administered for 23 days every calendar month. The regimen was well-tolerated, producing no major side-effects and was effective in relieving menopausal symptoms. The study showed that 40% of the women experienced side-effects and 20% withdrew from the study. Half of the 20% of the women who dropped out did so for reasons not related to treatment. All symptomatic women experienced improvement after the 1st month, and virtually all were asymptomatic by the 3rd month of treatment, persisting until the end of the trial with the average number of hot flushes per day declining from the pretreatment levels by 96%. Amenorrhea was observed in 47% of patients, amenorrhea and minimal vaginal bleeding in 78% but acyclic bleeding was present in 28% of those in whom bleeding was re-established. Endometrial atrophy was induced in the majority of patients and no atypical endometrial hyperplasia was encountered. No significant changes were observed in blood glucose or liver enzymes. The mean percentage changes from baseline for serum cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoproteins (LDL) and LDL/HDL ratio were -6%, +32% (p < 0.001), -16% (p < 0.05), +15% (p < 0.05) and -23% (p < 0.05), respectively. The regimen was clinically effective and its apparent lack of major side-effects, the protective effect on the endometrium, the added advantage of minimal vaginal bleeding and the beneficial effect on lipid/lipoprotein levels, offer an attractive therapy and improved compliance with postmenopausal hormone replacement therapy.
Collapse
Affiliation(s)
- I I Bolaji
- Department of Obstetrics and Gynaecology, University College Hospital, Galway, Ireland
| | | | | | | | | | | |
Collapse
|
20
|
Abstract
Comparison of necropsy records, clinical details and epidemiological data of 93 unexplained stillbirths and 149 cases of sudden infant death syndrome provides compelling evidence that these disorders represent a continuum of a single spectrum of disease. Regarding them as a single disease entity could lead to a clearer understanding of both.
Collapse
Affiliation(s)
- S Walsh
- Department of Pathology, University College Hospital, Galway, Ireland
| | | |
Collapse
|
21
|
Abstract
A case is presented of a laterally occurring thyroglossal cyst. In conventional teaching, thyroglossal duct remnants occupy the midline, or a position adjacent to the midline, and are found in a line marking the descent of the thyroid anlage and move upwards on protruding the tongue. Laterally presenting thyroglossal duct remnants are unusual.
Collapse
Affiliation(s)
- D M O'Hanlon
- Department of Surgery, Portiuncula General Hospital, Ballinasloe
| | | | | | | | | |
Collapse
|
22
|
Carson KD, Grimes SB, McGinley JM, Thornton MT, Mulhall J, Bourke AM, McCrory C, Marsh B, Hone R, Phelan D, White M, Fabry J, Hughes D, Carson K, Donnelly M, Shanahan E, Fitzpatrick GJ, Bourke M, Warde D, Buggy D, Hughes N, Taylor A, Dowd N, Markham T, Blunnie W, Nicholson G, O’Leary E, Cunningham AJ, Dwyer R, McMechan S, Cullen C, Dempsey G, Wright G, MacKenzie G, Anderson J, Adgey J, Walsh M, O’Callaghan P, Graham I, O’Hare JA, Geoghegan M, Iman N, Shah P, Chander R, Lavin F, Daly K, Johnston PW, Imam Z, Adgey AAJ, Rusk RA, Richardson SG, Hale A, Kinsella BM, FitzGerald GA, King G, Crean P, Gearty G, Cawley T, Docherty JR, Geraghty J, Osborne H, Upton J, D’Arcy G, Stinson J, Cooke T, Colgan MP, Hall M, Tyrrell J, Gaffney K, Grouden M, Moore DJ, Shanik G, Feely J, Delanty N, Reilly M, Lawson JA, Fitzgerald DJ, Reilly MP, McAdam BF, Bergin C, Walshe MJ, Herity NA, Allen JD, Silke B, Singh HP, O’Neill S, Hargrove M, Coleman E, Shorten E, Aherne T, Kelly BE, Hill DH, McIlrath E, Morrow BC, Lavery GG, Blackwood B, Fee JPH, Kevin L, Doran M, Tansey D, Boylan I, McShane AJ, O’Reilly G, Tuohy B, Grainger P, Larkin T, Mahady J, Malone J, Condon C, Donoghue T, O’Leary J, Lyons JF, Tay YK, Tham SN, Khoo Tan HS, Gibson G, O’Grady A, Leader M, Walshe J, Carmody M, Donohoe J, Murphy GM, O’Connor W, Barnes L, Watson R, Darby C, O’Moore R, Mulcahy F, O’Toole E, O’Briain DS, Young MM, Buckley D, Healy E, Rogers S, Ni Scannlain N, McKenna MJ, McBrinn Y, Murray B, Freaney R, Barrett E, Razza Q, Abuaisha F, Powell D, Murray TM, Powell AM, O’Mongain E, O’Neill J, Kernan RP, O’Connor P, Clarke D, Fearon U, Cunningham SK, McKenna TJ, Hayes F, Heffernan A, Sheahan K, Harper R, Johnston GD, Atkinson AB, Sheridan B, Bell PM, Heaney AP, Loughrey G, McCance DR, Hadden DR, Kennedy AL, McNamara P, O’Shaughnessy C, Loughrey HC, Reid I, Teahan S, Caldwell M, Walsh TN, McSweeney J, Hennessy TP, Caldwell MTP, Byrne PJ, Hennessy TPJ, El-Magbri AA, Stevens FM, O’Sullivan R, McCarthy CF, Laundon J, Heneghan MA, Kearns M, Goulding J, Egan EL, McMahon BP, Hegarty F, Malone JF, Merriman R, MacMathuna P, Crowe J, Lennon J, White P, Clarke E, Prabhakar MC, Ryan E, Graham D, Yeoh PL, Kelly P, McKeogh D, O’Keane C, Kitching A, Mulligan E, Gorey TF, Mahmud N, O’Connell M, Goggins M, Keeling PWN, Weir DG, Kelleher D, McDonald GSA, Maguire D, O’Sullivan G, Harvey B, Cherukuri A, McGrath JP, Timon C, Lawlor P, O’Shea J, Buckley M, English L, Walsh T, O’Morain C, Lavelle SM, Kanagaratnam B, Harding B, Murphy B, Kavanagh J, Kerr D, Lavelle E, O’Gorman T, Liston S, Fitzpatrick C, Fitzpatrick P, Turner M, Murphy AW, Cafferty D, Dowling J, Bury G, Kaf Al-Ghazal S, Zimmermann E, O’Donoghue J, McCann J, Sheehan C, Boissel L, Lynch M, Cryan B, Fanning S, O’Meara D, Fennell J, Byrne PM, Lyons D, Mulcahy R, Pooransingh A, Walsh JB, Coakley D, O’Neill D, Ryall N, Connolly P, Namushi R, Lawler M, Locasciulli A, Bacigalupo A, Humphries P, McCann SR, Pamphilon D, Reidy M, Madden M, Finch T, Borton M, Barnes CA, Lawlor SE, Gardiner N, Egan LJ, Orren A, Doherty J, Curran C, O’Hanlon D, Kent P, Kerin M, Maher D, Given HF, Lynch S, McManus R, O’Farrelly C, Madrigal L, Feighery C, O’Donoghue D, Whelan CA, Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TCM, Maguire H, Davidson F, Kaminski GZ, Butler K, Hillary IB, Parfrey NA, Crowley B, McCreary C, Keane C, O’Reilly M, Goh J, Kennedy M, Fitzgerald M, Scott T, Murphy S, Hildebrand J, Holliman R, Smith C, Kengasu K, Riain UN, Cormican M, Flynn J, Glennon M, Smith T, Whyte D, Keane CT, Barry T, Noone D, Maher M, Dawson M, Gilmartin JJ, Gannon F, Eljamel MS, Allcut D, Pidgeon CN, Phillips J, Rawluk D, Young S, Toland J, Deveney AM, Waddington JL, O’Brien DP, Hickey A, Maguire E, Phillips JP, Al-Ansari N, Cunney R, Smyth E, Sharif S, Eljamel M, Pidgeon C, Maguire EA, Burke ET, Staunton H, O’Riordan JI, Hutchinson M, Norton M, McGeeney B, O’Connor M, Redmond JMT, Feely S, Boyle G, McAuliffe F, Foley M, Kelehan P, Murphy J, Greene RA, Higgins J, Darling M, Byrne P, Kondaveeti U, Gordon AC, Hennelly B, Woods T, Harrison RF, Geary M, Sutherst JR, Turner MJ, DeLancey JOL, Donnelly VS, O’Connell PR, O’Herlihy C, Barry-Kinsella C, Sharma SC, Drury L, Lewis S, Stratton J, Ni Scanaill S, Stuart B, Hickey K, Coulter-Smith S, Moloney A, Robson MS, Murphy M, Keane D, Stronge J, Boylan P, Gonsalves R, Blankson S, McGuinness E, Sheppard B, Bonnar J, MacDonagh-White CM, Kelleher CC, Newell J, White O, Young Y, Hallahan C, Carroll K, Tipton K, McDermott EW, Reynolds JV, Nolan N, McCann A, Rafferty R, Sweeney P, Carney D, O’Higgins NJ, Duffy MJ, Grimes H, Gallagher S, O’Hanlon DM, Strattan J, Lenehan P, Robson M, Cusack YA, O’Riordain D, Mercer PM, Smyth PPA, Gallagher HJ, Moule B, Cooke TG, McArdle CS, Burke C, Vance A, Saidtéar C, Early A, Eustace P, Maguire L, Cullinane ABP, Prosser ES, Coca-Prados M, Harvey BJ, Saidléar C, Orwa S, Fitzsimons RB, Bradley O, Hogan M, Zimmerman L, Wang J, Kuliszewski M, Liu J, Post M, Premkumar, Conran MJ, Nolan G, Duff D, Oslizlok P, Denham B, O’Connell PA, Birthistle K, Hitchcock R, Carrington D, Calvert S, Holmes K, Smith DF, Hetherton AM, Mott MG, Oakhill A, Foreman N, Foot A, Dixon J, Walsh S, Mortimer G, O’Sullivan C, Kilgallen CM, Sweeney EC, Brayden DJ, Kelly JG, McCormack PME, Hayes C, Johnson Z, Dack P, Hosseini J, O’Connell T, Hemeryck L, Condren L, McCormack P, McAdam B, Lawson J, Keimowitz R, O’Leary A, Pilkington R, Adebayo GI, Gaffney P, McGettigan P, McManus J, O’Shea B, Wen Y, Killalea S, Golden J, Swanwick G, Clare AW, Mulvany F, Byrne M, O’Callaghan E, Byrne H, Cannon N, Kinsella T, Cassidy B, Shepard N, Horgan R, Larkin C, Cotter D, Coffey VP, Sham PC, Murray LH, Lane A, Kinsella A, Murphy P, Colgan K, Sloan D, Gilligan P, McEnri J, Ennis JT, Stack J, Corcoran E, Walsh D, Thornton L, Temperley I, Lawlor E, Tobin A, Hillary I, Nelson HG, Martin M, Ryan FM, Christie MA, Murray D, Keane E, Holmes E, Hollyer J, Strangeways J, Foster P, Stanwell-Smith R, Griffin E, Conlon T, Hayes E, Clarke T, Fogarty J, Moloney AC, Killeen P, Farrell S, Clancy L, Hynes M, Conlon C, Foley-Nolan C, Shelley E, Collins C, McNamara E, Hayes B, Creamer E, LaFoy M, Costigan P, Al fnAnsari N, Cunney RJ, Smyth EG, Johnson H, McQuoid G, Gilmer B, Browne G, Keogh JAB, Jefferson A, Smith M, Hennessy S, Burke CM, Sreenan S, Power CK, Pathmakanthan S, Poulter LW, Chan A, Sheehan M, Maguire M, O’Connor CM, FitzGerald MX, Southey A, Costello CM, McQuaid K, Urbach V, Thomas S, Horwitz ER, Mulherin D, FitzGerald O, Bresnihan B, Kirk G, Veale DJ, Belch JJF, Mofidi A, Mofidi R, Quigley C, McLaren M, Veale D, D’Arrigo C, Couto JC, Woof J, Greer M, Cree I, Belch J, Hone S, Fenton J, Hamilton S, McShane D. National Scientific Medical Meeting 1994 Abstracts. Ir J Med Sci 1994. [DOI: 10.1007/bf02943102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
23
|
Sullivan RP, Mortimer G, Muircheartaigh IO. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression. Ir J Med Sci 1993; 162:343-7. [PMID: 7903289 DOI: 10.1007/bf02942162] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Ki67 and Proliferating Cell Nuclear Antigen (PCNA) are antigens expressed in the nucleus during various phases of cell division, which can be detected immunohistochemically using monoclonal antibodies. Thirteen fibroadenomas and 39 carcinomas were examined for expression of Ki67 and PCNA. A staining index was calculated for each tumour as the percentage of positive cells in the areas of highest density. The mean index for both antibodies was significantly lower in fibroadenomas than in malignant tumours. A wide range of proliferation rates was seen in the malignant group; the mean Ki67 index of Grade I carcinomas was 9% +/- 4.4 (mean +/- SD), of Grade II 14.3 +/- 8.7 and of Grade III 26.2 +/- 15.7. These differences are statistically significant. In malignant tumours there was a good correlation between the mitotic count and the Ki67 index (r = 0.61, p < 0.005) but none between the mitotic count and PCNA index. There was a weak correlation between the Ki67 and the PCNA indices (r = 0.38 p < 0.005), but no correlation was found between either index and oestrogen receptor status, patient age or tumour size. Ki67 immunohistochemistry is a convenient method for assessing cell proliferation, applicable in most laboratories. The validity of measuring proliferation in this way has yet to be established but the wide variation of expression even within the conventional grading categories may help to discriminate prognostically distinct subgroups. Expression of PCNA appears to correlate poorly with Ki67 expression in breast tumours and not with mitotic count; therefore its usefulness as a marker of proliferative activity, on current evidence, appears to be limited.
Collapse
MESH Headings
- Adenocarcinoma, Mucinous/genetics
- Adenocarcinoma, Mucinous/metabolism
- Adenocarcinoma, Mucinous/pathology
- Antibodies, Monoclonal/analysis
- Antigens, Neoplasm/biosynthesis
- Antigens, Neoplasm/genetics
- Breast Neoplasms/genetics
- Breast Neoplasms/metabolism
- Breast Neoplasms/pathology
- Carcinoma, Ductal, Breast/metabolism
- Carcinoma, Ductal, Breast/pathology
- Cell Count
- Cell Division/genetics
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Ki-67 Antigen
- Macrophages/pathology
- Neoplasm Proteins/biosynthesis
- Neoplasm Proteins/genetics
- Nuclear Proteins/biosynthesis
- Nuclear Proteins/genetics
- Proliferating Cell Nuclear Antigen
Collapse
Affiliation(s)
- R P Sullivan
- Department of Histopathology, University College, Galway, Ireland
| | | | | |
Collapse
|
24
|
Abstract
Eighty-one epithelial lesions were studied immunohistologically for cytokeratin protein expression using three anticytokeratins CAM 5.2, NCL5D3 and RCK102. Consistent differences were noted between squamous and glandular neoplasms. Squamous and cutaneous carcinomas were found to preferentially express higher molecular weight cytokeratins than adenocarcinomas. In addition, tumours of similar morphology from different sites showed differences in expression of these markers. Differences in pattern were also found between benign and malignant lesions in the case of liver and urinary bladder. Thus the value of cytokeratin profile analysis in characterisation of epithelial neoplasms is confirmed and may be useful in distinguishing benign from malignant tumours in some instances.
Collapse
Affiliation(s)
- G Mortimer
- Department of Pathology, Security Forces Hospital, Riyadh, Kingdom of Saudi Arabia
| | | | | | | |
Collapse
|
25
|
|
26
|
Bolaji II, Grimes H, Mortimer G, Tallon DF, Fottrell PF, O'Dwyer EM. Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters. Eur J Obstet Gynecol Reprod Biol 1993; 48:61-8. [PMID: 8449263 DOI: 10.1016/0028-2243(93)90054-g] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
BACKGROUND Cardiovascular disease among older women is a major health problem and is the leading cause of death in this group in developed countries. The risk is reduced in oestrogen users secondary to favourable lipid changes, but the beneficial effect of oestrogen may be counteracted when concomitant progestogens are administered. OBJECTIVE To study the effects of a novel hormone replacement therapy regimen on liver enzymes, lipids and lipoproteins in postmenopausal women. DESIGN Prospective open, non-comparative trial for 12 months. METHODS 40 healthy postmenopausal women, (mean age +/- S.D.), 53.5 +/- 3 years received 0.625 mg of conjugated equine oestrogen daily and 100 mg of micronised oral progesterone (P) for the first 23 days every calendar month for 12 months without interruption. MAIN OUTCOME MEASURE Gonadotrophins, liver function parameters and lipoproteins were measured before treatment and at the 6th, 9th and 12th months of treatment. RESULTS Compliance with treatment was confirmed by a 33% decrease in mean serum level of follicle stimulating hormone at the end of 1 year of treatment. In the same period, the mean serum cholesterol, LDL and LDL/HDL ratio decreased by 6%, 16% and 23% of the base line levels, respectively. The percentage changes in triglycerides and HDL from the basal levels were +32% (P < 0.001) and +15% (P < 0.05), respectively. CONCLUSION These results indicate that near continuous administration of fixed low-dose of P has no adverse effects on the lipid milieu of postmenopausal women when combined with long-term continuous oestrogen replacement therapy provided women with borderline triglyceridaemia are excluded.
Collapse
Affiliation(s)
- I I Bolaji
- Department of Obstetrics and Gynaecology, University College, Galway, Ireland
| | | | | | | | | | | |
Collapse
|
27
|
Coulter J, Molloy RG, Moran KT, Waldron R, Kirwan WO, O’Suilleabhain C, Horgan A, Mealy K, Burke P, Hyland J, Horgan AF, Sheehan M, Browne RM, Austin O, Clery AP, Deasy JM, Sulaiman-Shoaib S, Soeda J, O’Briain DS, Puri P, Coveney EC, McAllister V, McDermott EWM, O’Higgins NJ, Maher M, Caldwell MTP, Murchan P, Beesley W, Feeley TM, Tanner WA, Keane FBV, Abbasakoor F, Attwood SEA, McGrath LP, Stephens RB, O’Broin E, Davies MG, McGinley J, Mannion C, Gupta S, Shine MF, Lennon F, Ninan G, Fitzgerald RJ, Guiney EJ, O’Donnell B, O’Donnell AF, Luke D, Wood AE, Murphy PG, Walsh TN, Hill ADK, Li H, Hennessy TPJ, Noonan N, Breslin B, Keeling PWN, Curran AJ, Gough DB, Davidson IR, Keeling P, O’Leary DP, Smythe A, Bird NC, Johnson AG, Nicholson P, Traynor O, Dawson K, Aitken J, Cooke BA, Parbhoo SP, N.Williams N, Daly JM, Herlyn M, Bouchier-Hayes D, Stuart RC, Allen MJ, Thompson WD, Peel ALG, Hehir DT, Cronin K, McCann A, Dervan PA, Heffernan SJ, Hederman WP, Galea MH, Dilks B, Gilmour A, Ellis LO, Elston CW, Blarney RW, O’Rourke S, Mookens A, Carter R, Parkin D, Couse NF, Delaney CP, Horgan PG, Fitzpatrick JM, Gorey TF, O’Byrne JM, McCabe JP, Stephens M, McManus F, L.Mangan J, Barr DA, Mulvenna GJ, Maginn P, Kernohan WG, Mollan RAB, O’Flanagan SJ, Stack JP, Dervan P, Hurson B, Tierney S, Fitzgerald P, O’Sullivan T, Grace P, Wyatt JP, Evans RJ, Cusack SP, McGowan S, McGovem E, Schwaitzberg SD, Connolly RJ, Sullivan RP, Mortimer G, Geraghty JG, O’Dwyer PJ, McGlone BS, O’Brien DP, Younis HA, Given HF, Phelan C, Byrne J, Barry K, Gough D, Hanrahan L, Given F, Sweeney JP, Korebrits AM, Reynolds JV, Gorey TF, O’Hanlon DM, Stokes MA, Redmond HP, McCarthy J, Daly JM, Losty P, Murphy M, Butler PEM, Grace PG, Novell JR, Hobbs SK, Smith O, Hazlehurst G, Brozovic B, Rolles K, Burroughs A, Mallett S, Mehta A, Buckley D, Waldron D, O’Brien D, Curran C, Given F, Grey L, Leahy A, Darzi A, Leader D, Broe P, Geoghegan JG, Cheng CA, Lawson DC, Pappas TN, O’Sullivan D, Lieber MM, Colby TV, Barrett DM, Rogers E, Greally J, Bredin HC, Corcoran MO, Kenny M, Horgan P, Headon D, Grace A, Grace PA, Bouchier-Hayes D, Cross S, Hehir D, O’Briain S, Hartigan P, Colgan MP, Moore D, Shanik G, Zaidi SZ, Hehir DJ, Cross KS, Colgan MP, Moore DJ, Shanik DG, Lacy P, Cross S, Hehir D, Moore D, Shanik G, Coleman JE, McEnroe CS, Gelfand JA, O’Donnell TF, Callow AD, Buckley DJ, O’Riordain DS, O’Donnell JA, Meagher P, Boos K, Gillen P, Corrigan T, Vashisht R, Sian M, Sharp EJ, O’Malley MK, Kerin MJ, Wilkinson D, Parkin A, Kester RC, Maher MM, Waldron RP, Waldron DJ, Brady MP, Allen M, Lyncy TH, Waymont B, Emtage L, Blackledge GR, Hughes MA, Wallace DMA, O’Sullivan D, Mynderse L, Barrett DM, Rogers E, Grimes H, Chambers F, Lowe D, Bredin HC, Corcoran MO, Waldron DJ, Prasad B, O’Sullivan DC, Gillen MBP, McNicholas M, Traynor O, Bredin H, O’Dowd TH, Corcoran M, O’Donoghue JM, Corcoran M, McGuire M, McNamara A, Creagh T, Grainger R, McDermott TBD, Butler MR, Gleeson M, Creagh T, Grainger R, McDermott TED, Hurley JP, Hone R, Neligan M, Hurley J, White M, McDonagh P, Phelan D, McGovern E, Quinn F, Breatnach F, O’Meara A, McGrath JP, McCann SR, Gaffney EF, Hennessy A, Leader M, Taleb FS, McKiernan MV, Leyden PJ, McCann JJ, Coleman J, Quereshi A, Ajayi N, McEntee G, Osborne H, Bouchier-Hayes DJ, Johnston S, O’Malley K, Smyth E, Bouchier-Hayes DL, Darzi A, Quereshi A, McEntee G, O’Connell PR, Gorey T, McAnena OJ, Reed MW, Duncan JL, Reilly CS, McGibney C, Lawlor P, Lawless B, McGuinness E, Leahy S. Sixteenth sir peter freyer memorial lecture and surgical symposium September 13th & 14th, 1991 Session I. Ir J Med Sci 1992. [DOI: 10.1007/bf02942125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Devany DM, Corbally N, Carney DN, Dervan PA, Sullivan RP, Mortimer G, McNamara E, Landers RJ, Sheehan M, O’Briain DS, Cormican MG, McDermott M, Gillen J. Royal academy of medicine in Ireland section of pathology. Ir J Med Sci 1992. [DOI: 10.1007/bf02942093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
29
|
Bolaji II, Mortimer G, Meehan FP, England S, Greally M. Acardius in a triplet pregnancy: cytogenetic and morphological profile. Acta Genet Med Gemellol (Roma) 1992; 41:27-32. [PMID: 1488853 DOI: 10.1017/s0001566000002476] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
We describe a rare case of acardius in a triplet pregnancy terminated by Caesarean Section at 32 weeks gestation. Morphological and chromosomal abnormalities of the fetus as well as structural abnormalities of the placenta are presented. Cytogenetic analysis and examination of the single disc triplet placenta provide evidence for the two major theories of pathogenesis of acardius, the twin reversed arterial perfusion (TRAP) sequence and the genetic theory, which we believe are not necessarily mutually exclusive.
Collapse
Affiliation(s)
- I I Bolaji
- Department of Obstetrics and Gynaecology, University College Hospital, Galway, Ireland
| | | | | | | | | |
Collapse
|
30
|
Bolaji II, Mortimer G, Long SV. Gynaecological short communication Update on the histopathology of spontaneous abortion material: A prospective analysis. J OBSTET GYNAECOL 1992. [DOI: 10.3109/01443619209013616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
31
|
|
32
|
Abstract
A survey of 325 stillbirths from 27,072 babies delivered at University College Hospital Galway from April 1, 1972 to March 31, 1982, gave a stillbirth rate of 12 per thousand, which, when corrected for 66 lethal congenital abnormalities, became 9.6 per thousand. The cause of death in each stillbirth was determined clinically and pathologically where possible and was classified according to a modified Aberdeen classification of perinatal death. Consideration of the birth weights of the babies who died showed that 223 (68.6%) weighed over 1,500 g, and excluding those with abnormalities, they must be considered salvageable with the application of intensive neonatal care. There were 54 (16.6%) intrapartum deaths, which must also be considered preventable. The application of ultrasonic surveillance should complement clinical acumen, by allowing easier detection of the fetus at risk, thereby facilitating earlier intervention which in turn should reduce antenatal stillbirths.
Collapse
Affiliation(s)
- I M Magani
- Department of Obstetrics and Gynaecology, University College Hospital, Galway, Ireland
| | | | | | | |
Collapse
|
33
|
Glazier JJ, Mortimer G, Daly KM. A clinical role for right ventricular endomyocardial biopsy. Ir Med J 1989; 82:153-5. [PMID: 2621076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
There is considerable uncertainty about the value of endomyocardial biopsy (EMB) in the diagnosis and management of patients with suspected primary myocardial dysfunction. To determine the clinical utility of this procedure in patients referred to our centre, we reviewed the clinical records and biopsy findings of the first 21 consecutive patients in whom we performed right ventricular EMB. Patients were divided into four groups according to the clinical indications for EMB: unexplained congestive cardiac failure and a dilated heart (Group 1: 11 patients); unexplained congestive cardiac failure and a non dilated heart (Group 2: three patients); unexplained cardiomegaly in the absence of cardiac failure (Group 3: one patient); suspected hypertrophic cardiomyopathy (HCM) (Group 4: six patients). Histological examination of EMB tissue obtained from all patients in Group 1 as well as the single patient in Group 3 showed non specific features judged to be compatible with a diagnosis of dilated cardiomyopathy. Accordingly, in all patients in Groups 1 and 3, a potentially treatable cause of primary myocardial dysfunction was excluded. Biopsy examination demonstrated the presence of a specific disease process in two of three patients in Group 2 (one patient had amyloidosis, the other endomyocardial fibrosis). In five of the six patients in Group 4, the biopsy findings were either diagnostic or suggestive of HCM. Our results suggest that EMB is a clinically useful tool in patients presenting with features suggestive of a primary myocardial disorder.
Collapse
|
34
|
Abstract
The distribution of pregnancy-associated prostaglandin synthetase inhibitor (PAPSI) has been studied in 181 human placentae and early products of conception using a peroxidase-antiperoxidase (PAP) immunohistological method. PAPSI was detected in amniotic epithelium throughout all stages of gestation. Extravillous trophoblast was PAPSI-positive throughout gestation. Villous trophoblast was PAPSI-positive in the first 12 weeks of gestation, when PAPSI was localized to syncytiotrophoblast but not to cytotrophoblast. Villous syncytio- and cytotrophoblast were both PAPSI-negative from 12 weeks to term. Fetal and maternal polymorphs contained PAPSI at all stages of gestation, as did villous Hofbauer cells. The significance of these findings is discussed in relation to putative functions of PAPSI, particularly the maintenance of pregnancy and control of onset of parturition.
Collapse
Affiliation(s)
- G Mortimer
- University Department of Pathology, Royal Infirmary, Glasgow, U.K
| | | | | |
Collapse
|
35
|
|
36
|
Abstract
A study of perinatal mortality in multiple pregnancy over a period of 12 years, 1972 to 1984, showed prematurity and low birthweight as the major causes of fetal loss. The highest risk was found at 28 to 30 weeks gestation (306/1,000). There was a significantly greater risk to babies delivered by the breech (136/1,000), and likewise in the second twin when compared with the first, ratio 1:14. A significant drop in the perinatal mortality rate, from 98/1,000 to 39/1,000, was observed between 1972-1978 and 1979-1984. Ultrasound has facilitated the earlier diagnosis of twins and provides more accurate serial fetal assessment. Bedrest, more vigilant antenatal care, intrapartum surveillance and improved neonatal care, are required to maintain and further reduce the perinatal mortality rate. When regional analgesia was employed in labour, the number of babies lost was 41/1,000, vs 93/1,000 in patients not receiving regional analgesia. External cephalic version and vertex delivery of the second twin is preferable to internal version and breech extraction. It should also be contemplated, as an alternative to elective cesarean section for a transverse lie or breech presentation of the second fetus.
Collapse
Affiliation(s)
- F P Meehan
- Department of Obstetrics and Gynaecology, University College Galway, Ireland
| | | | | |
Collapse
|
37
|
Abstract
To test the assumption that monochorionic twins are monozygotic, cord bloods from 12 sets of monochorionic twins were tested for a total of 16 red cell antigens. Discrepancies were noted among the minor blood groups in 3 of the 12 sets. The result of this pilot study strengthens the contention of others who have previously questioned the general acceptance that monochorionicity and monozygosity are synonymous.
Collapse
Affiliation(s)
- G Mortimer
- University Department of Pathology, Royal Infirmary and Royal Maternity Hospital, Glasgow, UK
| |
Collapse
|
38
|
Tolmie JL, Mortimer G, Doyle D, McKenzie R, McLaurin J, Neilson JP. The Neu-Laxova syndrome in female sibs: clinical and pathological features with prenatal diagnosis in the second sib. Am J Med Genet 1987; 27:175-82. [PMID: 3300330 DOI: 10.1002/ajmg.1320270118] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
We report on affected sisters with the Neu-Laxova syndrome. Prenatal diagnosis of the condition was achieved by serial ultrasound examinations which demonstrated abnormal fetal growth in the second affected fetus before 24 weeks gestation.
Collapse
|
39
|
Abstract
A 24-week fetus with GM1 gangliosidosis (type 1) was studied using biochemical and histopathologic methods. Foam cells in viscera and placenta demonstrated widespread accumulation of a lipidlike material. By microscopy, central nervous system storage appeared confined to the retina and dorsal root ganglia, but the brain ganglioside content was measurably elevated compared with that of age-matched controls. These data, along with those of others, imply that, if the observed pathologic findings are irreversible, any attempts at intrauterine therapy must commence prior to the middle of the second trimester.
Collapse
|
40
|
Abstract
The prevalence of inflammatory villous lesions was determined in a prospective study of 120 consecutive placentas. Cord blood IgM level was measured as an indicator of fetal intrauterine infection, and the birthweights of the infants were noted. Ten cases of villitis were found. Two infants had elevated cord blood IgM and one of them also had amniotic infection. As only one case of villitis had corroborative evidence of transplacental intrauterine infection, 90% of the lesions require an alternative explanation. The severity of the lesions correlated with the presence of low birthweight. The quality of the inflammatory infiltrate was also considered. Only one case included plasma cells; the remainder showed lymphohistiocytic infiltration. The case with plasmacytic infiltration was the one with elevated cord blood IgM. It is concluded that placental villitis is usually not an infective condition and its aetiology remains unknown.
Collapse
|
41
|
Abstract
A peroxidase anti-peroxidase staining technique was used to determine the presence of pregnancy-associated prostaglandin synthetase inhibitor (PAPSI) in human amniotic epithelium from 20 pregnant women at 36-40 weeks' gestation. PAPSI was present in amniotic epithelial cells in 12 of 15 women before the onset of labour. No PAPSI was found in amniotic epithelium from 5 women in clinically established labour. These findings indicate that the amnion is a source of this endogenous prostaglandin synthetase inhibitor and suggest a local role for amniotic epithelium in initiating labour at term.
Collapse
|
42
|
Abstract
Fraser syndrome without cryptophthalmos is described in monozygotic twins concordant for bilateral renal agenesis.
Collapse
|
43
|
Abstract
The cardiac conduction systems of three patients who died in the perinatal period were studied histologically. Rhythm disturbances were observed in these patients immediately before death. The sinus node was notably hypoplastic without increase in fibrous content in all cases. The atrioventricular node was smaller than expected in all, and the entire atrioventricular conduction axis was small in two cases. This study supports the need for a detailed examination of the cardiac conduction system so as to provide a better understanding of the clinicoanatomical relation in the context of fatal perinatal arrhythmias.
Collapse
|
44
|
Abstract
Four children each exhibiting a profound deficiency of phytanic acid oxidase activity in cultured skin fibroblasts but with very different phenotypes, are described. A consistently raised plasma phytanic acid value, generally considered to be pathognomonic for Refsum's disease (phytanic acid oxidase deficiency), was observed in three of these children but not in the fourth, who also showed no evidence of accumulation of phytanic acid in liver or fat biopsies. Our data suggest that the clinical diagnosis of Refsum's disease in children is more difficult because the full spectrum of clinical features usually observed in adults with the disorder is not always present. Moreover, a failure to detect a raised plasma phytanic acid value may not necessarily indicate normal fibroblast phytanic acid oxidase activity.
Collapse
|
45
|
Abstract
We report the unique observation of monozygotic twins concordant for bilateral renal agenesis.
Collapse
|
46
|
|
47
|
Abstract
Seven cases of recurring digital fibroma were seen over a 35-year period. All demonstrated the classical clinical, macroscopic, and microscopic features of this distinct tumour, including the pathognomonic round, eosinophilic cytoplasmic inclusion bodies. Ultrastructurally, all seven cases were confirmed to be myofibroblastic in nature, and the morphology and intracellular topography of the inclusion bodies suggested their derivation from contractile protein. These findings establish recurring digital fibroma as a neoplastic lesion of the myofibroblast.
Collapse
|
48
|
Abstract
A case of parathyroiditis with epithelial hyperplasia is reported in which the histological features suggest an autoimmune process analogous to Hashimoto's disease.
Collapse
|
49
|
Mortimer G, Casey M. Serum acid phosphatase activities in patients with lung cancer: a biochemical and immunohistochemical analysis of 25 cases. J Clin Pathol 1981; 34:958-62. [PMID: 7024327 PMCID: PMC494201 DOI: 10.1136/jcp.34.9.958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
A series of 25 cases of lung cancer are presented in which total (TAcP) and nonprostatic serum acid phosphatase (NPAcP) activities were measured. Of these cases, 36% had raised TAcP and NPAcP activities in their serum. However, the serum activities of TAcP and NPAcP did not correlate with either the presence of lung cancer nor with the morphological tumour type. This fact indicates that, despite isolated reports of raised serum acid phosphatase activities in cases of lung cancer, acid phosphatase is of no value as a marker for lung cancer. We sought alternative explanations for the raised TAcP and NPAcP activities observed in our series in the hope that this enzyme might prove useful as a marker for early metastatic disease in lung cancer patients. This possibility is not substantiated, and the findings are analyzed and discussed. It is tentatively suggested that raised NPAcP activities in patients with lung cancer may relate to haemostasis.
Collapse
|
50
|
|